2 minute read

MBHB Partner Kevin Noonan Quoted in BioWorld Article Entitled, "Flaws In The IPR Process Give Rise To Some Very Inventive Patent Solutions”

Kevin E. Noonan, Ph.D.September 20, 2017

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a September 20, 2017 edition of BioWorld in an article entitled, “Flaws in the IPR process give rise to some very inventive patent solutions.” Before making a mad dash to follow Allergan plc’s lead in handing off key patents to an Indian tribe to avoid inter partes reviews (IPRs), other drug and med-tech companies may want to watch from the sidelines to see how the U.S. Supreme Court rules in a case that could doom the entire IPR process. View the article